首页> 外文OA文献 >Results of Expert Council meeting on modern principles of treatment optimization in patients with relapsing-remitting multiple sclerosis using anti-CD20 monoclonal antibody

【2h】

Results of Expert Council meeting on modern principles of treatment optimization in patients with relapsing-remitting multiple sclerosis using anti-CD20 monoclonal antibody

机译：使用抗CD20单克隆抗体复发延迟多发性硬化症患者现代治疗优化原则专家委员会的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
A. N. Boyko; N. V. Khachanova; D. S. Korobko; D. S. Kasatkin; Ya. V. Vlasov; E. P. Evdoshenko; E. V. Popova; K. Z. Bakhtiyarova; S. A. Sivertseva;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Differential reconstitution of T cell subsets following immunodepleting treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with relapsing-remitting multiple sclerosis [J] . ZhangX., TaoY., ChopraM., The Journal of Immunology: Official Journal of the American Association of Immunologists . 2013,第12期

机译：复发缓解型多发性硬化症患者用alemtuzumab（抗CD52单克隆抗体）免疫耗竭治疗后T细胞亚群的差异性重建
2. Monoclonal antibody therapies for the treatment of relapsing-remitting multiple sclerosis: differentiating mechanisms and clinical outcomes. [J] . Jan Lycke Therapeutic advances in neurological disorders. . 2015,第6期

机译：复发缓解型多发性硬化症的单克隆抗体疗法：区分机制和临床结果。
3. Monoclonal antibody therapies for the treatment of relapsing-remitting multiple sclerosis: differentiating mechanisms and clinical outcomes [J] . Jan Lycke Therapeutic advances in neurological disorders. . 2015,第6期

机译：复发缓解型多发性硬化症的单克隆抗体疗法：鉴别机制和临床结果
4. Predicting Future Disease Activity and Treatment Responders for Multiple Sclerosis Patients Using a Bag-of-Lesions Brain Representation [C] . Andrew Doyle, Doina Precup, Douglas L. Arnold, International conference on medical imaging computing and computer-assisted intervention . 2017

机译：使用病变袋大脑表示法预测多发性硬化症患者的未来疾病活动和治疗反应者
5. An investigation of early relapsing-remitting multiple sclerosis patients using diffusion tensor imaging and spectroscopy. [D] . Zaini, Wan Hazlin. 2013

机译：使用扩散张量成像和光谱法对早期复发缓解型多发性硬化症患者进行调查。
6. Monoclonal antibody therapies for the treatment of relapsing-remitting multiple sclerosis: differentiating mechanisms and clinical outcomes [O] . Jan Lycke 2015

机译：复发缓解型多发性硬化症的单克隆抗体疗法：鉴别机制和临床结果
7. A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis [O] . Edward Fox, Amy E Lovett-Racke, Matthew Gormley, 2020

机译：患有多发性硬化形式的患者的新型甘油蛋白抗CD20单克隆抗体的ublituximab的2多中心研究

Results of Expert Council meeting on modern principles of treatment optimization in patients with relapsing-remitting multiple sclerosis using anti-CD20 monoclonal antibody

著录项

引文网络

相似文献

相关主题

期刊订阅